Chengdu Ruihede Pharmaceutical (est. 2018) established subsidiary Deyang Ruihede Pharmaceutical in 2021.

Specializing in pharmaceutical/agrochemical/biotech/material sectors, core services:

• Novel drug CRO

• Custom intermediates R&D and production

• Generic drug & fine chemicals process optimization

The company has been certified as a National High-Tech Enterprise and has obtained ISO 9001:2015 certification and holds more than 30 patents.

Ruihe De R & D team now has more than 10 R & D personnel at all levels of Ben, Shuo and Bo. Start-up five core technical personnel, from different chemical and chemical sub-fields, so that the R & D team in route development, process development, continuous synthesis technology, equipment selection and plant construction management have a complete knowledge structure and practical management experience. In the industry, the team has advanced concepts, leading technology, good equipment and clean and compliant office environment. On this basis, the company will establish and build a perfect R & D and production platform for customers.